To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Bill 118 hjres 99, also known as the Premium Cigar Exemption Act, aims to amend the Federal Food, Drug, and Cosmetic Act to provide an exemption for the premium cigar industry from certain regulations. The bill seeks to relieve premium cigar manufacturers and retailers from burdensome regulations that are currently imposed on other tobacco products.

The premium cigar industry has argued that the regulations imposed by the Food and Drug Administration (FDA) are overly burdensome and unnecessary for their products, which are typically handmade and have a limited consumer base. Supporters of the bill believe that premium cigars should be treated differently from other tobacco products due to their unique characteristics and the fact that they are not marketed towards youth.

If passed, the Premium Cigar Exemption Act would provide relief to the premium cigar industry by exempting them from regulations such as premarket review requirements and warning label mandates. Proponents of the bill argue that this exemption would allow the industry to continue operating without facing unnecessary regulatory hurdles that could potentially harm their businesses. Opponents of the bill, however, argue that exempting the premium cigar industry from certain regulations could have negative public health implications, as it may lead to increased consumption of these products. They believe that all tobacco products should be subject to the same regulations in order to protect public health and prevent youth initiation. Overall, Bill 118 hjres 99 seeks to provide regulatory relief to the premium cigar industry by exempting them from certain regulations under the Federal Food, Drug, and Cosmetic Act. The bill has sparked debate among lawmakers and stakeholders, with supporters arguing that the exemption is necessary to protect the industry, while opponents raise concerns about potential public health risks.